Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia

Authors:

Abstract
This randomized trial investigates the efficacy of 3 different doses of bevacizumab nasal spray for reducing epistaxis duration in patients with hereditary hemo